Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IPG7236 |
Synonyms | |
Therapy Description |
IPG7236 inhibits CCR8 expressed on tumor-infiltrating regulatory T cells, potentially leading to an increased antitumor immune response and decreased tumor growth (PMID: 36988587). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IPG7236 | IPG 7236|IPG-7236 | IPG7236 inhibits CCR8 expressed on tumor-infiltrating regulatory T cells, potentially leading to an increased antitumor immune response and decreased tumor growth (PMID: 36988587). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05142592 | Phase I | IPG7236 | IPG7236 in Patients With Advanced Solid Tumors | Recruiting | USA | 0 |